About
Elmedical provides an office-based system composed of a console and catheters designed for minimally invasive, non-ablative, high-temperature treatments (hyperthermia) for unmet urological diseases such as bladder cancer and prostatitis. Bladder wall thermochemotherapy (BWT) provides chemotherapy instillation at a uniform and precise 44 to 44.5 degrees Celsius over the entire bladder lumen. To secure drug stability and achieve an exact and uniform temperature, BWT uses a carefully heated mitomycin C solution at a predetermined hyperthermia temperature that circulates through the bladder in a high flow, with the entire contents of the bladder replaced four to five times per minute. In BWT, the heat content of the circulating solution exceeds what is required to transfer to the thermally conductive bladder wall. DuoThermia for chronic prostatitis/chronic pelvic pain syndrome in males is the simultaneous hyperthermia treatment of the prostate and bladder administered by a heated balloon in the prostatic urethra and free circulation of a heated saline in the bladder. Approximately 8,500 BWT and DuoThermia procedures have been successfully performed, with good patient tolerance both during and after the procedures.
Company Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- What is Elmedical's primary focus in the medical field?
- Elmedical specializes in providing office-based systems for minimally invasive, non-ablative, high-temperature treatments (hyperthermia) for urological diseases like bladder cancer and prostatitis.
- When was Elmedical founded?
- Elmedical was founded in April 2003.
- What are the two main products offered by Elmedical?
- Elmedical offers two main products: DuoThermia and Bladder Wall Thermochemotherapy (BWT).
- How many procedures have been successfully performed using Elmedical's BWT and DuoThermia systems?
- Approximately 8,500 BWT and DuoThermia procedures have been successfully performed.
- In which countries does Elmedical have a geographic market presence?
- Elmedical has a geographic market presence in Denmark, Italy, Spain, Austria, Switzerland, Greece, Germany, Croatia, and Turkey.
- What is the core technology behind Elmedical's Bladder Wall Thermochemotherapy (BWT)?
- BWT involves chemotherapy instillation at a uniform and precise 44 to 44.5 degrees Celsius over the entire bladder lumen, using a heated mitomycin C solution that circulates through the bladder at a high flow.
- What is the purpose of Elmedical's DuoThermia treatment?
- DuoThermia is designed for the simultaneous hyperthermia treatment of the prostate and bladder for chronic prostatitis/chronic pelvic pain syndrome in males.
- How many employees does Elmedical currently have?
- Elmedical currently has 2 employees.